Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2006 by Dr. Wayne Holman, Ridgeback Capital Management is based in New York City. This private investment firm specializes in securities trading and long-term investments, primarily in the life sciences sector. The firm has a portfolio of over 100 companies, focusing on both private and public entities.
Ridgeback Capital invests in companies dedicated to developing life-saving and life-changing therapies in the biotech and healthcare sectors. The firm emphasizes patient capital, which is crucial for the growth of new technologies and companies in healthcare. Their investments span both private and public companies.
Ridgeback Capital has funded over 100 biopharma companies, contributing to the development of transformative medicines. A notable initiative includes the collaboration with Ridgeback Biotherapeutics on a COVID-19 treatment pill.
Email info@ridgebackcap.com with your deck to pitch Ridgeback Capital.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.